RTP Mobile Logo

Correlation of BRCA Mutation Status with Responses to Platinum Therapy and PARP Inhibitors in Patients with Ovarian Cancer and Triple-Negative Breast Cancer (TNBC)

Bevacizumab in the Primary Treatment of Advanced Ovarian, Peritoneal or Fallopian Tube Carcinoma

5MJC Multimumor A

Pellentesque urna enim, mattis nec rhoncus eget, pharetra mattis quam. Phasellus nibh nibh, aliquet sit amet molestie eget

Year in Review – Multiple Myeloma: 2009-2010

Year in Review – Multiple Myeloma: 2009-2010

Consensus or Controversy, Issue 7: Clinical Assays to Assist in the Management of Breast Cancer

Consensus or Controversy, Issue 6: Therapy in Locally Advanced and Metastatic Disease

Consensus or Controversy, Issue 5: New Treatment and Biology Paradigms in Triple-Negative Breast Cancer (TNBC)

Consensus or Controversy, Issue 4: Practical Decisions Related to the Anti-Angiogenic Treatment of Breast Cancer

Consensus or Controversy, Issue 3: Common Adjuvant Scenarios

Consensus or Controversy, Issue 2: Endocrine Therapy; Bone Target Therapy

Consensus or Controversy, Issue 1: Adjuvant Therapy of HER2-Positive Tumors

TNBC Test

Please enable JavaScript to view this KnowledgeVision player.

Finding the Positives in Triple-Negative Breast Cancer

Meet The Professors — Clinical Investigators Consult on Challenging Actual Cases of Patients with Gastrointestinal Cancers

Meet The Professors — Clinical Investigators Consult on Challenging Actual Cases of Patients with Gastrointestinal Cancers